dactinomycin and Canine Diseases

dactinomycin has been researched along with Canine Diseases in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	3 (37.50)	18.2507
2000's	2 (25.00)	29.6817
2010's	2 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amores-Fuster, I; Blackwood, L; Elliott, J; Finotello, R; Grant, IA; Harper, A; Killick, DR; Marrington, M; Mas, A; Smallwood, K; Tanis, JB	1
Monteith, G; Parsons-Doherty, M; Poirier, VJ	1
Bannink, EO; Hauptman, JG; Mullins, MN; Obradovich, JE; Sauerbrey, ML	1
Dank, G; Jakubiak, MJ; Kass, PH; Kent, MS; Lyons, J; Siedlecki, CT	1
Frimberger, AE; Moore, AS; Schelling, SH	1
Bell, FW; Goulland, EL; Hayden, DW; Khanna, C; Klausner, JS; Lund, EM; Redic, KA	1
Aoki, M; Katamoto, H; Kotani, T; Kubo, K; Kuwamura, M; Nomura, K; Ohashi, F; Sasaki, N	1
Stein, E	1

Trials

2 trial(s) available for dactinomycin and Canine Diseases

Article	Year
The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma. The Canadian veterinary journal = La revue veterinaire canadienne, 2014, Volume: 55, Issue:2 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Dexamethasone; Dog Diseases; Dogs; Female; Lymphoma; Male; Melphalan; Recurrence; Retrospective Studies	2014
Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. Journal of the American Veterinary Medical Association, 1998, Oct-01, Volume: 213, Issue:7 Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Dactinomycin; Dog Diseases; Dogs; Double-Blind Method; Doxorubicin; Female; Gastrointestinal Diseases; Lymphoma, Non-Hodgkin; Male; Neutropenia; Remission Induction; Survival Analysis; Time Factors	1998

Article

Year

The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.

The Canadian veterinary journal = La revue veterinaire canadienne, 2014, Volume: 55, Issue:2

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Dexamethasone; Dog Diseases; Dogs; Female; Lymphoma; Male; Melphalan; Recurrence; Retrospective Studies

2014

Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.

Journal of the American Veterinary Medical Association, 1998, Oct-01, Volume: 213, Issue:7

Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Dactinomycin; Dog Diseases; Dogs; Double-Blind Method; Doxorubicin; Female; Gastrointestinal Diseases; Lymphoma, Non-Hodgkin; Male; Neutropenia; Remission Induction; Survival Analysis; Time Factors

1998

Other Studies

6 other study(ies) available for dactinomycin and Canine Diseases

Article	Year
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience. Veterinary and comparative oncology, 2019, Volume: 17, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Dactinomycin; Databases, Factual; Dexamethasone; Dog Diseases; Dogs; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Schools, Veterinary; Thrombocytopenia; Treatment Outcome; United Kingdom	2019
Actinomycin D as rescue therapy in dogs with relapsed or resistant lymphoma: 49 cases (1999--2006). Journal of the American Veterinary Medical Association, 2008, Aug-01, Volume: 233, Issue:3 Topics: Animals; Antibiotics, Antineoplastic; Dactinomycin; Disease-Free Survival; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Lymphoma; Male; Neoplasm Recurrence, Local; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Thrombocytopenia; Time Factors; Treatment Outcome	2008
Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma. The Canadian veterinary journal = La revue veterinaire canadienne, 2006, Volume: 47, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Disease-Free Survival; Dog Diseases; Dogs; Female; Lymphoma; Male; Prognosis; Remission Induction; Retrospective Studies; Sex Factors; Time Factors; Treatment Outcome	2006
Treatment of nephroblastoma in a juvenile dog. Journal of the American Veterinary Medical Association, 1995, Sep-01, Volume: 207, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dactinomycin; Dog Diseases; Dogs; Doxorubicin; Fatal Outcome; Female; Kidney Neoplasms; Vincristine; Wilms Tumor	1995
In vitro cytotoxicity of recombinant human-TNF-alpha and actinomycin D on canine normal and tumor cells. The Journal of veterinary medical science, 1998, Volume: 60, Issue:10 Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cell Survival; Cells, Cultured; Dactinomycin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Kidney; Kidney Neoplasms; Male; Mammary Neoplasms, Animal; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1998
[Data on toxicity and various therapeutic results of antineoplastic antibiotics in the dog]. Tierarztliche Praxis, 1973, Volume: 1, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Azaserine; Bleomycin; Chlortetracycline; Cycloheximide; Dactinomycin; Dog Diseases; Dogs; Fatty Acids, Unsaturated; Leucomycins; Mitomycins; Neoplasms; Oleandomycin; Olivomycins; Oxytetracycline; Streptozocin	1973